ArticleHeliyon2024

The different sequences of CDK4/6 inhibitor and mTOR inhibitor in HR+/HER2-advanced breast cancer: A multicenter real-world study.

Yuqian Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.